COCO SILVIA

Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186(May 2025) [10.1016/j.biopha.2025.118044]. Dettaglio

Costanzi, E., Grisetti, M., Bettucci, M., Meanti, R., Lonati, E., Morello, G., et al. (2025). Exploring the role of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease: the impact of MSC preconditioning on targeted therapeutic efficacy. Intervento presentato a: ISEV2025 Annual Meeting, Vienna. Dettaglio

Meanti, R., Licata, M., Rizzi, L., Bresciani, E., Molteni, L., Coco, S., et al. (2023). Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24020993]. Dettaglio

Meanti, R., Bresciani, E., Rizzi, L., Coco, S., Zambelli, V., Dimitroulas, A., et al. (2023). Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis. CURRENT NEUROPHARMACOLOGY, 21(12), 2376-2394 [10.2174/1570159X20666220915103613]. Dettaglio

Rizzi, L., Turati, M., Bresciani, E., Anghilieri, F., Meanti, R., Molteni, L., et al. (2022). Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears. BIOMEDICINES, 10(11) [10.3390/biomedicines10112909]. Dettaglio